date,title,source
Oct-24-18,"Analysis: Positioning to Benefit within Spectrum Pharmaceuticals, Carnival, Cadence Design, Tandem Diabetes Care, Rigel Pharmaceuticals, and Regeneron Pharmaceuticals  Research Highlights Growth, Revenue, and Consolidated Results",GlobeNewswire
Oct-29-18,"Rigel Pharmaceuticals Enters Collaboration and License Agreement with Kissei Pharmaceutical Co., Ltd. to Develop and Commercialize TAVALISSE (fostamatinib disodium hexahydrate) in Japan and other Asian Countries",PR Newswire
Oct-30-18,Rigel Announces Conference Call and Webcast to Report Third Quarter 2018 Financial Results,PR Newswire
